Lyytinen H - Search Results

1

Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC-MS/MS (liquid chromatography-tandem mass spectrometry) method for estrogen measurement.

Faltinová M, Vehmanen L, Lyytinen H, Haanpää M, Hämäläinen E, Tiitinen A, Blomqvist C, Mattson J. Faltinová M, et al. Among authors: lyytinen h. Breast Cancer Res Treat. 2023 Oct;201(3):425-435. doi: 10.1007/s10549-023-07054-3. Epub 2023 Jul 25. Breast Cancer Res Treat. 2023. PMID: 37491651 Free PMC article. Clinical Trial.

2

Monitoring serum estradiol levels in breast cancer patients during extended adjuvant letrozole treatment after five years of tamoxifen: a prospective trial.

Faltinová M, Vehmanen L, Lyytinen H, Haanpää M, Hämäläinen E, Tiitinen A, Blomqvist C, Mattson J. Faltinová M, et al. Among authors: lyytinen h. Breast Cancer Res Treat. 2021 Jun;187(3):769-775. doi: 10.1007/s10549-021-06168-w. Epub 2021 Mar 12. Breast Cancer Res Treat. 2021. PMID: 33710439 Clinical Trial.

3

A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well.

Lyytinen HK, Dyba T, Ylikorkala O, Pukkala EI. Lyytinen HK, et al. Int J Cancer. 2010 Jan 15;126(2):483-9. doi: 10.1002/ijc.24738. Int J Cancer. 2010. PMID: 19588504 Free article.

4

Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.

Koskela-Niska V, Pukkala E, Lyytinen H, Ylikorkala O, Dyba T. Koskela-Niska V, et al. Among authors: lyytinen h. Int J Cancer. 2015 Oct 15;137(8):1947-52. doi: 10.1002/ijc.29549. Epub 2015 Apr 21. Int J Cancer. 2015. PMID: 25846583 Free article.

5

Do the dose or route of administration of norethisterone acetate as a part of hormone therapy play a role in risk of breast cancer: national-wide case-control study from Finland.

Lyytinen H, Dyba T, Pukkala E, Ylikorkala O. Lyytinen H, et al. Int J Cancer. 2010 Jul 1;127(1):185-9. doi: 10.1002/ijc.24996. Int J Cancer. 2010. PMID: 19859914 Free article.

6

Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study.

Jaakkola S, Lyytinen HK, Dyba T, Ylikorkala O, Pukkala E. Jaakkola S, et al. Int J Cancer. 2011 Apr 1;128(7):1644-51. doi: 10.1002/ijc.25762. Epub 2011 Jan 12. Int J Cancer. 2011. PMID: 21280035 Free article.

7

Breast cancer risk in postmenopausal women using estrogen-only therapy.

Lyytinen H, Pukkala E, Ylikorkala O. Lyytinen H, et al. Obstet Gynecol. 2006 Dec;108(6):1354-60. doi: 10.1097/01.AOG.0000241091.86268.6e. Obstet Gynecol. 2006. PMID: 17138766

8

Breast cancer risk in postmenopausal women using estradiol-progestogen therapy.

Lyytinen H, Pukkala E, Ylikorkala O. Lyytinen H, et al. Obstet Gynecol. 2009 Jan;113(1):65-73. doi: 10.1097/AOG.0b013e31818e8cd6. Obstet Gynecol. 2009. PMID: 19104361

9

Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.

Koskela-Niska V, Pukkala E, Lyytinen H, Ylikorkala O, Dyba T. Koskela-Niska V, et al. Among authors: lyytinen h. Int J Cancer. 2013 Oct 1;133(7):1680-8. doi: 10.1002/ijc.28167. Epub 2013 Apr 16. Int J Cancer. 2013. PMID: 23526244 Free article.

10

Vaginal estradiol use and the risk for cardiovascular mortality.

Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O. Mikkola TS, et al. Among authors: lyytinen h. Hum Reprod. 2016 Apr;31(4):804-9. doi: 10.1093/humrep/dew014. Epub 2016 Feb 13. Hum Reprod. 2016. PMID: 26874358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page